The Transfection of BDNF to Dopamine Neurons Potentiates the Effect of Dopamine D3 Receptor Agonist Recovering the Striatal Innervation, Dendritic Spines and Motor Behavior in an Aged Rat Model of Parkinson’s Disease
Open accessAbstract
The progressive degeneration of the dopamine neurons of the pars compacta of substantia nigra and the consequent loss of the dopamine innervation of the striatum leads to the impairment of motor behavior in Parkinson's disease. Accordingly, an efficient therapy of the disease should protect and regenerate the dopamine neurons of the substantia nigra and the dopamine innervation of the striatum. Nigral neurons express Brain Derived Neurotropic Factor (BDNF) and dopamine D3 receptors, both of which protect the dopamine neurons. The chronic activation of dopamine D3 receptors by their agonists, in addition, restores, in part, the dopamine innervation of the striatum. Here we explored whether the over-expression of BDNF by dopamine neurons potentiates the effect of the activation of D3 receptors restoring nigrostriatal innervation. Twelve-month old Wistar rats were unilaterally injected with 6-hydroxydopamine into the striatum. Five months later, rats were treated with the D3 agonist 7-hydroxy-N,N-di-n-propy1-2-aminotetralin (7-OH-DPAT) administered i.p. during 4½ months via osmotic pumps and the BDNF gene transfection into nigral cells using the neurotensin-polyplex nanovector (a non-viral transfection) that selectively transfect the dopamine neurons via the high-affinity neurotensin receptor expressed by these neurons. Two months after the withdrawal of 7-OH-DPAT when rats were aged (24 months old), immunohistochemistry assays were made. The over-expression of BDNF in rats receiving the D3 agonist normalized gait and motor coordination; in addition, it eliminated the muscle rigidity produced by the loss of dopamine. The recovery of motor behavior was associated with the recovery of the nigral neurons, the dopamine innervation of the striatum and of the number of dendritic spines of the striatal neurons. Thus, the over-expression of BDNF in dopamine neurons associated with the chronic activation of the D3 receptors appears to be a promising strategy for restoring dopamine neurons in Parkinson's disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Gene transfection of BDNF into a 6-hydroxydopamine-induced unilateral lesion in the striatum reverts motor deficits in an animal model of Parkinson's disease.
“gene transfection of BDNF into a 6-hydroxydopamine-induced unilateral lesion in the striatum was able to revert motor deficits in this animal model of PD [203].”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529 · see citing works
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.
Prut, L., & Belzung, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01272-x · Cited by 3,190 · see citing works
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650 · see citing works
The open-field test: A critical review.
WALSH, R. N., & Cummins, R. A. (1976) · Psychological Bulletin · doi:10.1037/0033-2909.83.3.482 · Cited by 2,389 · see citing works
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494 · see citing works
Fritsch, B., Reis, J., Martinowich, K., Schambra, H. M., Ji, Y., Cohen, L. G., & Lu, B. (2010) · Neuron · doi:10.1016/j.neuron.2010.03.035 · Cited by 1,420 · see citing works
Putting a spin on the dorsal-ventral divide of the striatum
Voorn, P., Vanderschuren, L. J. M. J., Groenewegen, H. J., Robbins, T. W., & Pennartz, C. M. A. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.006 · Cited by 1,188 · see citing works
Carola, V., D'Olimpio, F., Brunamonti, E., Mangia, F., & Renzi, P. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00452-1 · Cited by 735 · see citing works
Kirik, D., Rosenblad, C., & Björklund, A. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6848 · Cited by 663 · see citing works
The basal ganglia: learning new tricks and loving it
Graybiel, A. M. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.10.006 · Cited by 650 · see citing works
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Guillin, O., Díaz, J., Carroll, P., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (2001) · Nature · doi:10.1038/35075076 · Cited by 573 · see citing works
The role of neuronal growth factors in neurodegenerative disorders of the human brain
Connor, B. J., & Dragunow, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00004-6 · Cited by 534 · see citing works
Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra
Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513 · see citing works
Takakusaki, K., Habaguchi, T., Ohtinata-Sugimoto, J., Saitoh, K., & Sakamoto, T. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00095-2 · Cited by 409 · see citing works
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00463-2 · Cited by 394 · see citing works
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease
Zaja-Milatovic, S., Milatovic, D., Schantz, A. M., Zhang, J., Montine, K. S., Samii, A., Deutch, A. Y., & Montine, T. J. (2005) · Neurology · doi:10.1212/01.wnl.0000150591.33787.a4 · Cited by 300 · see citing works
Ingham, C. A., Hood, S. H., Taggart, P., & Arbuthnott, G. W. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04732.1998 · Cited by 291 · see citing works
Evidence of a breakdown of corticostriatal connections in Parkinson’s disease
Stephens, B., Mueller, A., Shering, A. F., Hood, S. H., Taggart, P., Arbuthnott, G. W., Bell, J. E., Kilford, L., Kingsbury, A. E., Daniel, S. E., et al. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.007 · Cited by 284 · see citing works
Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
Chio, C. L., Lajiness, M. E., & Huff, R. M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09903-1 · Cited by 255 · see citing works
The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism
Rozas, G., López-Martín, M. E., Guerra, M. J., & Labandeira-García, J. L. (1998) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(98)00078-8 · Cited by 225 · see citing works
Durieux, P. F., Schiffmann, S. N., & d’Exaerde, A. D. K. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.400 · Cited by 206 · see citing works
Blöchl, A., & Sirrenberg, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21100 · Cited by 183 · see citing works
Takakusaki, K., Tomita, N., & Yano, M. (2008) · Journal of Neurology · doi:10.1007/s00415-008-4004-7 · Cited by 181 · see citing works
Lévesque, D., Martres, M., Díaz, J., Griffon, N., Lammers, C.-H., Sokoloff, P., & Schwartz, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1719 · Cited by 180 · see citing works
Graft‐induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio
Politis, M., Oertel, W. H., Wu, K., Quinn, N. P., Pogarell, O. M., Brooks, D. J., Björklund, A., Lindvall, O., & Piccini, P. P. (2011) · Movement Disorders · doi:10.1002/mds.23743 · Cited by 176 · see citing works
Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease
Glajch, K. E., Fleming, S. M., Surmeier, D. J., & Osten, P. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.007 · Cited by 174 · see citing works
Genetic mouse models of parkinsonism: Strengths and limitations
Fleming, S. M., Fernagut, P., & Chesselet, M. (2005) · NeuroRx · doi:10.1602/neurorx.2.3.495 · Cited by 172 · see citing works
Kampen, J. M. V., Hagg, T., & Robertson, H. A. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03342.x · Cited by 168 · see citing works
Wictorin, K., Simerly, R. B., Ole Isacson, A., Swanson, L. W., & Björklund, A. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90256-x · Cited by 145 · see citing works
Zheng, J., Shen, W., Lu, T., Zhou, Y., Chen, Q., Wang, Z., Xiang, T., Zhu, Y.-C., Zhang, C., Duan, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709930200 · Cited by 142 · see citing works
BDNF Enhances the Functional Reinnervation of the Striatum by Grafted Fetal Dopamine Neurons
Yurek, D. M., Lu, W. Y.-R., Hipkens, S. B., & Wiegand, S. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0011 · Cited by 140 · see citing works
Characterization of the 5′-flanking region of the human dopamine transporter gene
Sacchetti, P., Brownschidle, L. A., Granneman, J. G., & Bannon, M. J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00275-2 · Cited by 135 · see citing works
Self-citationKampen, J. M. V., & Eckman, C. B. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0837-06.2006 · Cited by 133 · see citing works
Connor, B. J., Kozlowski, D. A., Schallert, T. J., Tillerson, J. L., Davidson, B. L., & Bohn, M. C. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301033 · Cited by 129 · see citing works
Díaz, J., Ridray, S., Mignon, V., Griffon, N., Schwartz, J., & Sokoloff, P. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04282.1997 · Cited by 124 · see citing works
Pilon, C., Lévesque, D., Dimitriadou, V., Griffon, N., Martres, M., Schwartz, J., & Sokoloff, P. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90182-1 · Cited by 122 · see citing works
Cenci, M. A., Campbell, K., Wictorin, K., & Björklund, A. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00885.x · Cited by 119 · see citing works
Du, F., Li, R., Huang, Y., Li, X., & Le, W. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04438.x · Cited by 117 · see citing works
Goggi, J., Pullar, I. A., Carney, S. L., & Bradford, H. F. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02505-2 · Cited by 116 · see citing works
Rozas, G., & Labandeira-García, J. L. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01162-6 · Cited by 113 · see citing works
Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease
Ryoo, H., Pierrotti, D., & Joyce, J. N. (1998) · Movement Disorders · doi:10.1002/mds.870130506 · Cited by 112 · see citing works
Lindner, M. D., Cain, C. K., Plone, M. A., Frydel, B. R., Blaney, T. J., Emerich, D. F., & Hoane, M. R. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(98)00160-0 · Cited by 107 · see citing works
Metz, G. A. S., Tse, A. D. Y., Ballermann, M. A., Smith, L. K., & Fouad, K. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04238.x · Cited by 105 · see citing works
Kampen, J. M. V., & Robertson, H. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.054 · Cited by 101 · see citing works
Somatotopic organization in rat striatum: evidence for a combinational map.
Brown, L. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7403 · Cited by 99 · see citing works
Lindsay, R. M. (1995) · Nature · doi:10.1038/373289a0 · Cited by 98 · see citing works
Coronas, V., Bantubungi, K., Fombonne, J., Krantic, S. M., Schiffmann, S. N., & Roger, M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02823.x · Cited by 94 · see citing works
Solís, Ó., Limón, I. D., Flores‐Hernández, J., & Flores, G. (2007) · Synapse · doi:10.1002/syn.20381 · Cited by 94 · see citing works
Effect of skin movement on the analysis of hindlimb kinematics during treadmill locomotion in rats
Filipe, V. M. D. J., Pereira, J. E., Maltez, L., Maurício, A. C., Couto, P., Melo‐Pinto, P., & Varejão, A. S. P. (2005) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2005.10.006 · Cited by 88 · see citing works
Jaunarajs, K. L. E., Dupre, K. B., Ostock, C. Y., Button, T., Terrence Deak, B., & Bishop, C. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833e7e80 · Cited by 87 · see citing works
Shen, R. Y., Altar, C. A., & Chiodo, L. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8920 · Cited by 87 · see citing works
Dopamine stimulation of postnatal murine subventricular zone neurogenesis via the D3 receptor
Kim, Y., Wang, W., Comte, I., Pastrana, É., Tran, P. B., Brown, J., Miller, R. J., Doetsch, F. K., Molnár, Z., & Szele, F. G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06799.x · Cited by 84 · see citing works
Metabolic mapping of rat striatum: somatotopic organization of sensorimotor activity
Brown, L. L., & Sharp, F. R. (1995) · Brain Research · doi:10.1016/0006-8993(95)00457-2 · Cited by 82 · see citing works
Ávila-Costa, M. R., Colín-Barenque, L., van der Goes, T. I. F., Machado-Salas, J. P., Espinosa-Villanueva, J., Rugerio-Vargas, C., & Rivas-Arancibia, S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00458-9 · Cited by 78 · see citing works
Wang, X. H., Lü, G., Hu, X., Tsang, K. S., Kwong, W. H., Wu, F., Meng, H., Jiang, S., Liu, S. W., Ng, H., et al. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-142 · Cited by 78 · see citing works
González-Barrios, J. A., Lindahl, M., Bannon, M. J., Anaya-Martı́nez, V., Flores, G., Navarro-Quiroga, I., Trudeau, L., Aceves, J., Martinez-Arguelles, D. B., Garcı́a-Villegas, R., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.09.001 · Cited by 77 · see citing works
Self-citationIm, S. H., Yu, J. H., Park, E. S., Lee, J. E., Kim, H. O., Park, K. I., Kim, G. W., Park, C. I., & Cho, S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.038 · Cited by 73 · see citing works
Ávila-Costa, M. R., Montiel-Flores, E., Colín-Barenque, L., Ordoñez, J. L., Gutiérrez, A. L., NIÑO-CABRERA, H. G., Mussali-Galante, P., & van der Goes, T. I. F. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000026398.86113.7d · Cited by 69 · see citing works
Soderstrom, K. E., O’Malley, J. A., Levine, N. D., Sortwell, C. E., Collier, T. J., & Steece‐Collier, K. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07077.x · Cited by 64 · see citing works
Zhou, J., Bradford, H. F., & STERN, G. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91376-5 · Cited by 62 · see citing works
Zhou, J., Bradford, H. F., & Stern, G. M. (1994) · Developmental Brain Research · doi:10.1016/0165-3806(94)90318-2 · Cited by 62 · see citing works
Griffon, N., Pilon, C., Sautel, F., Schwartz, J.-C., & Sokoloff, P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010001.x · Cited by 59 · see citing works
Growth factors in Parkinson's disease
Unsicker, K. (1994) · Progress in Growth Factor Research · doi:10.1016/0955-2235(94)90018-3 · Cited by 59 · see citing works
Peters, C., Espinoza, M. P., Gallegos, S., Opazo, C., & Aguayo, L. G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.019 · Cited by 56 · see citing works
NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease
Martínez‐Fong, D., Bannon, M. J., Trudeau, L., González-Barrios, J. A., Arango-Rodríguez, M. L., Hernández‐Chan, N. G., Reyes-Corona, D., Armendáriz‐Borunda, J., & Navarro-Quiroga, I. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.02.009 · Cited by 56 · see citing works
Self-citationSokoloff, P., Guillin, O., Díaz, J., Carroll, P., & Griffon, N. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000045499 · Cited by 52 · see citing works
Navarro-Quiroga, I., González-Barrios, J. A., Barron-Moreno, F., González-Bernal, V., Martinez-Arguelles, D. B., & Martínez‐Fong, D. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00396-0 · Cited by 51 · see citing works
Collo, G., Zanetti, S., Missale, C., & Spano, P. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06423.x · Cited by 51 · see citing works
Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone.
Double, K. L., & Crocker, A. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1669 · Cited by 44 · see citing works
Álvarez-Maya, I., Navarro-Quiroga, I., Meraz‐Ríos, M. A., Aceves, J., & Martínez‐Fong, D. (2001) · Molecular Medicine · doi:10.1007/bf03401952 · Cited by 41 · see citing works
Zhou, J., Bradford, H. F., & STERN, G. M. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00019-9 · Cited by 38 · see citing works
6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra
Venero, J. L., Beck, K. D., & Hefti, F. F. (1994) · Neuroreport · doi:10.1097/00001756-199401120-00014 · Cited by 36 · see citing works
Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease.
Singh, S. T., Ahmad, R., Mathur, D., Sagar, R., & Krishana, B. (2006) · PubMed · Cited by 36 · see citing works
Dopaminergic innervation of the human striatum in Parkinson's disease
Porritt, M. J., Stanić, D., Finkelstein, D. I., Batchelor, P., Lockhart, S. M., Hughes, A. J., Kalnins, R. M., & Howells, D. W. (2005) · Movement Disorders · doi:10.1002/mds.20399 · Cited by 34 · see citing works
Quantitative video-based gait pattern analysis for hemiparkinsonian rats
Lee, H.-Y., Hsieh, T.-H., Liang, J.-I., Yeh, M., & Chen, J.-J. J. (2012) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-012-0933-5 · Cited by 30 · see citing works
Biophysical characteristics of neurotensin polyplex for in vitro and in vivo gene transfection
Arango-Rodríguez, M. L., Navarro-Quiroga, I., González-Barrios, J. A., Martinez-Arguelles, D. B., Bannon, M. J., Kouri, J. B., Forgez, P., Rostène, W. H., Garcı́a-Villegas, R., Jiménez, I., et al. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.02.021 · Cited by 30 · see citing works
Self-citationViñuela, Á., Hallett, P. J., Reske-Nielsen, C., Patterson, M., Sotnikova, T. D., Caron, M. G., Gainetdinov, R. R., & Ole Isacson, A. (2008) · Brain · doi:10.1093/brain/awn192 · Cited by 30 · see citing works
Dickerson, J. W., Hemmerle, A. M., Numan, S., Lundgren, K. H., & Seroogy, K. B. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.008 · Cited by 29 · see citing works
Effects of 7-OH-DPAT and U 99194 on the behavioral response to hot plate test, in rats
Casarrubea, M., Sorbera, F., & Crescimanno, G. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.07.014 · Cited by 23 · see citing works
Dopamine cell transplantation in Parkinson's disease: challenge and perspective
Ma, Y., Peng, S., DHAWAN, V. M., & Eidelberg, D. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr040 · Cited by 23 · see citing works
Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain
Polinski, N. K., Gombash, S. E., Manfredsson, F. P., Lipton, J. W., Kemp, C. J., Cole-Strauss, A., Kanaan, N. M., Steece‐Collier, K., Kuhn, N. C., Wohlgenant, S. L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.047 · Cited by 21 · see citing works
Optimizing NTS-Polyplex as a Tool for Gene Transfer to Cultured Dopamine Neurons
Hernández-Baltazar, D., Martínez‐Fong, D., & Trudeau, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051341 · Cited by 18 · see citing works
Shin, E., Lisci, C., Tronci, E., Fidalgo, C., Stancampiano, R., Björklund, A., & Carta, M. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.021 · Cited by 18 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [39]Paxinos G, Watson C (1998) The rat brain: academic press 117 p.
Cited by
Sorted by citations
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750 · see citing works
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 534 · see citing works
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504 · see citing works
Cavalleri, L., Merlo Pich, E., Millan, M. J., Chiamulera, C., Kunath, T., Spano, P. F., & Collo, G. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.241 · Cited by 156 · see citing works
Eyileten, C., Sharif, L., Wicik, Z., Jakubik, D., Jarosz-Popek, J., Soplińska, A., Postula, M. A., Członkowska, A., Kapłon‐Cieślicka, A., & Mirowska-Guzel, D. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02101-2 · Cited by 144 · see citing works
Hirsch, M. A., van Wegen, E. E. H., Newman, M. A., & Heyn, P. C. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0112-1 · Cited by 134 · see citing works
Hernández-Baltazar, D., Zavala-Flores, L. M., & Villanueva-Olivo, A. (2015) · Neurología · doi:10.1016/j.nrl.2015.06.011 · Cited by 133 · see citing works
The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model
Hernández-Baltazar, D., Zavala-Flores, L. M., & Villanueva-Olivo, A. (2017) · Neurología (English Edition) · doi:10.1016/j.nrleng.2015.06.019 · Cited by 131 · see citing works
Collo, G., Cavalleri, L., Bono, F., Mora, C., Fedele, S., Invernizzi, R., Gennarelli, M., Piovani, G., Kunath, T., Millan, M., et al. (2018) · Journal of Neural Transplantation and Plasticity · doi:10.1155/2018/4196961 · Cited by 55 · see citing works
BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
Bazzari, A. H., & Bazzari, F. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158417 · Cited by 91 · see citing works
Human behavioral assessments in current research of Parkinson’s disease
Asakawa, T., Fang, H., Sugiyama, K., Nozaki, T., Kobayashi, S. S., Hong, Z., Suzuki, K., Mori, N., Yang, Y., Hua, F., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.036 · Cited by 75 · see citing works
Ren, M., Han, M., Wei, X., Guo, Y., Shi, H., Zhang, X., Perez, R. G., & Lou, H. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2125-4 · Cited by 68 · see citing works
Animal behavioral assessments in current research of Parkinson’s disease
Asakawa, T., Fang, H., Sugiyama, K., Nozaki, T., Hong, Z., Yang, Y., Hua, F., Ding, G., Chao, D., Fenoy, A. J., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.016 · Cited by 68 · see citing works
Nie, S., Yan, X., Chen, G., Ma, K., Han, C., Guo, Z., Zhang, Z., Ye, K., & Cao, X. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.016 · Cited by 65 · see citing works
Tronci, E., Napolitano, F., Muñoz, A., Fidalgo, C., Rossi, F., Björklund, A., Usiello, A., & Carta, M. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.017 · Cited by 57 · see citing works
Souza, R. B., Frota, A. F., de Sousa, R. S., Cezario, N. A., Santos, T. B., Souza, L. M. F., Coura, C. O., Monteiro, V. S., Filho, G. C., Vasconcelos, S. M. M., et al. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12669 · Cited by 57 · see citing works
Overcoming barriers in non-viral gene delivery for neurological applications
Tasset, A., Bellamkonda, A., Wang, W., Pyatnitskiy, I., Ward, D. M., Peppas, N. A., & Wang, H. (2022) · Nanoscale · doi:10.1039/d1nr06939j · Cited by 54 · see citing works
Neurodegenerative signaling factors and mechanisms in Parkinson's pathology
Goswami, P., Joshi, N., & Singh, S. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.06.008 · Cited by 50 · see citing works
Yang, M., Moon, C., Kim, J., Lee, S., Kang, S., Kim, S., & Kim, J.-C. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.217353 · Cited by 48 · see citing works
Blecharz‐Klin, K., Wawer, A., Jawna, K., Pyrzanowska, J., Piechal, A., Mirowska-Guzel, D. M., & Widy‐Tyszkiewicz, E. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.03.004 · Cited by 46 · see citing works
Schaeffer, E., Röeben, B., Granert, O., Hanert, A., Liepelt‐Scarfone, I., Leks, E., Otterbein, S., Saraykin, P., Busch, J., Synofzik, M., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15165 · Cited by 43 · see citing works
Szarowicz, C., Steece‐Collier, K., & Caulfield, M. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23148011 · Cited by 41 · see citing works
Teli, P., Kale, V. P., & Vaidya, A. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03821-2 · Cited by 37 · see citing works
Soto-Rojas, L. O., Martínez-Dávila, I. A., Luna-Herrera, C., Gutiérrez-Castillo, M. E., López-Salas, F. E., Gatica-García, B., Soto-Rodríguez, G., Bringas, M. E., Flores, G., Padilla-Viveros, A., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00933-6 · Cited by 35 · see citing works
ERRγ ligand HPB2 upregulates BDNF-TrkB and enhances dopaminergic neuronal phenotype
Kim, H. I., Lee, S., Lim, J., Chung, S.-K., Koo, T., Ji, Y.-G., Suh, Y., Son, W. S., Kim, S., & Choi, H. J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105423 · Cited by 29 · see citing works
Hassani, O. K., Rymar, V. V., Nguyen, K. Q., Huo, L., Cloutier, J., Miller, F. D., & Sadikot, A. F. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.014 · Cited by 28 · see citing works
Influence of BDNF genetic polymorphisms in the pathophysiology of aging-related diseases
Urbina-Varela, R., Soto-Espinoza, M. I., Vargas, R., Quiñones, L., & del Campo, A. (2020) · Aging and disease · doi:10.14336/ad.2020.0310 · Cited by 27 · see citing works
Suresh, K., Raavi, V., Kumar, M. H., & Shankar, V. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.12.002 · Cited by 27 · see citing works
Current Landscape and Emerging Opportunities of Gene Therapy with Non-viral Episomal Vectors
Khan, S. U., Khan, M. U., Khan, M. I., Kalsoom, F., & Zahra, A. (2022) · Current Gene Therapy · doi:10.2174/1566523222666221004100858 · Cited by 26 · see citing works
Delivery of neurotrophic factors in the treatment of age-related chronic neurodegenerative diseases
Padmakumar, S., Taha, M. S., Kadakia, E., Bleier, B. S., & Amiji, M. M. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1727443 · Cited by 25 · see citing works
Reyes-Corona, D., Vázquez-Hernández, N., Escobedo, L., Orozco-Barrios, C. E., Ayala-Dávila, J., Moreno, M. G., Amaro-Lara, M. E., Flores-Martinez, Y. M., Espadas-Álvarez, A. J., Fernandez-Parrilla, M. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188239 · Cited by 23 · see citing works
Mercado, N. M., Stancati, J. A., Sortwell, C. E., Mueller, R. L., Boezwinkle, S. A., Duffy, M. F., Fischer, D. L., Sandoval, I. M., Manfredsson, F. P., Collier, T. J., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105175 · Cited by 23 · see citing works
Wang, T., Wang, L., Li, C., Han, B., Wang, Z., Li, J., Lv, Y. Y., Wang, S., & Fu, F. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2176-1 · Cited by 22 · see citing works
Dombi, Z. B., Szendi, I., & Burnet, P. W. J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.827322 · Cited by 22 · see citing works
Espadas-Álvarez, A. J., Bannon, M. J., Orozco-Barrios, C. E., Escobedo, L., Ayala-Dávila, J., Reyes-Corona, D., Soto-Rodríguez, G., Escamilla‐Rivera, V., Vizcaya‐Ruíz, A. D., Gutiérrez-Castillo, M. E., et al. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.02.006 · Cited by 22 · see citing works
Self-citationLi, Y., Xia, B., Li, R., Yin, D., & Wenmei, L. (2017) · Medical Science Monitor · doi:10.12659/msm.904670 · Cited by 20 · see citing works
The effect of preventive exercise on the neuroprotection in 6-hydroxydopamine-lesioned rat brain
Rezaee, Z., Marandi, S. M., Alaei, H., & Esfarjani, F. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0545 · Cited by 20 · see citing works
Sheeler, C. A., Rosa, J. S., Borgenheimer, E., Mellesmoen, A., Rainwater, O., & Cvetanović, M. (2021) · The Cerebellum · doi:10.1007/s12311-020-01226-3 · Cited by 19 · see citing works
Kumari, S., Kamiya, A., Karnik, S. S., Rohilla, S., Dubey, S. K., & Taliyan, R. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04260-y · Cited by 19 · see citing works
Casanova, Y., Negro, S., & Barcia, E. (2021) · Acta Pharmaceutica · doi:10.2478/acph-2022-0008 · Cited by 17 · see citing works
Mahalakshmi, A. M., Ray, B., Tuladhar, S., Hediyal, T. A., Raj, P., Rathipriya, A. G., Qoronfleh, M. W., Essa, M. M., & Chidambaram, S. B. (2021) · Cells · doi:10.3390/cells10123405 · Cited by 16 · see citing works
Ghasemzadeh, Z., Sardari, M., Javadi, P., & Rezayof, A. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146885 · Cited by 15 · see citing works
Exercise-Induced Neuroprotection in the 6-Hydroxydopamine Parkinson’s Disease Model
Rezaee, Z., Marandi, S. M., Alaei, H., & Esfarjani, F. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00189-x · Cited by 15 · see citing works
Han, N., Kim, H., Kim, N., Lee, W., Jeong, H., Kim, H., & Jeong, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8335 · Cited by 15 · see citing works
Hassab, L. Y., Abbas, S. S., Mohammed, R. A., & Abdallah, D. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1133863 · Cited by 13 · see citing works
Wang, L., Kang, Y., Zhang, G., Zhang, Y., Cui, R., Yan, W., Tan, H., Li, S., Wu, B., Cui, H., et al. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.03.003 · Cited by 13 · see citing works
Hurtado, J. C., Berrío, J. P., Rodrigues, C., Zancan, M., Wink, M. R., & de Oliveira, A. A. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24442 · Cited by 12 · see citing works
Sarabia-Estrada, R., Ruiz‐Valls, A., Shah, S. R., Ahmed, A.-K., Ordoñez, A. A., Rodríguez, F. J., Guerrero‐Cazares, H., Jiménez‐Estrada, I., Velarde, E., Tyler, B., et al. (2017) · Journal of Neurosurgery Spine · doi:10.3171/2016.12.spine16917 · Cited by 11 · see citing works
Gan, J., He, J., Zhou, K., Shang, Z., Dong, G., Bao, D., & Zhou, J. (2024) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2024.12.004 · Cited by 10 · see citing works
Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose
Aranda-Barradas, M. E., Márquez, M., Quintanar, L., Santoyo‐Salazar, J., Espadas-Álvarez, A. J., Martínez‐Fong, D., & García-García, E. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010005 · Cited by 10 · see citing works
Sarabia-Estrada, R., Ruiz‐Valls, A., Guerrero‐Cazares, H., Ampuero, A. M., Jiménez‐Estrada, I., Silva, S. D., Bernhardt, L. J., Goodwin, C. R., Ahmed, A. K., Li, Y., et al. (2017) · The Spine Journal · doi:10.1016/j.spinee.2017.04.009 · Cited by 9 · see citing works
Gatica-García, B., Bannon, M. J., Martínez-Dávila, I. A., Soto-Rojas, L. O., Reyes-Corona, D., Escobedo, L., Maldonado-Berny, M., Gutiérrez-Castillo, M. E., Espadas-Álvarez, A. J., Fernandez-Parrilla, M. A., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.391190 · Cited by 8 · see citing works
Self-citationSabaghi, A., Heirani, A., Yousofvand, N., Sabaghi, S., & Sadeghi, F. (2020) · Sport Sciences for Health · doi:10.1007/s11332-020-00661-3 · Cited by 8 · see citing works
Hernández-Baltazar, D., Nadella, R., Rovirosa-Hernández, M. D. J., Zavala-Flores, L. M., & Rosas-Jarquín, C. D. J. (2018) · InTech eBooks · doi:10.5772/intechopen.71271 · Cited by 8 · see citing works
p70S6K on astrocytes protects dopamine neurons from 1‐methyl‐4‐phenylpyridinium neurotoxicity
Kim, K. I., Baek, J. Y., Chung, Y. C., Nam, J. H., Shin, W., & Jin, B. K. (2021) · Glia · doi:10.1002/glia.24013 · Cited by 8 · see citing works
BDNF Val66Met Polymorphism: Suggested Genetic Involvement in Some Children with Learning Disorder
Elhadidy, M. E., Kilany, A., Gebril, O. H., Nashaat, N. H., Zeidan, H. M., Elsaied, A., Hashish, A. F., & Raouf, E. R. A. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02095-7 · Cited by 7 · see citing works
Benítez-Castañeda, A., Anaya-Martı́nez, V., Espadas-Álvarez, A. J., Gutiérrez-Valdez, A. L., Razgado-Hernández, L. F., Reyna-Velazquez, P. E., Quintero-Macías, L., Martínez‐Fong, D., Florán, B., & Aceves, J. (2024) · Parkinson s Disease · doi:10.1155/2024/3885451 · Cited by 7 · see citing works
Self-citationJadidi, M., Biat, S. M., Sameni, H. R., Safari, M., Vafaei, A. A., & Ghahari, L. (2016) · PubMed Central · Cited by 7 · see citing works
Mascotte-Cruz, J. U., Vera, A., Leija, L., López-Salas, F. E., Gradzielski, M., Koetz, J., Gatica-García, B., Rodríguez-Oviedo, C. P., Valenzuela-Arzeta, I. E., Escobedo, L., et al. (2024) · Discover Nano · doi:10.1186/s11671-024-04005-9 · Cited by 6 · see citing works
López-Salas, F. E., Nadella, R., Maldonado-Berny, M., Escobedo-Sanchez, M. L., Fiorentino-Pérez, R., Gatica-García, B., Fernandez-Parrilla, M. A., Gil, M. M., Reyes-Corona, D., Garcı́a, U., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00755 · Cited by 6 · see citing works
Martínez‐Fong, D., Fernandez-Parrilla, M. A., Reyes-Corona, D., Flores-Martinez, Y. M., Nadella, R., Bannon, M. J., Escobedo, L., Maldonado-Berny, M., Santoyo‐Salazar, J., Soto-Rojas, L. O., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.321001 · Cited by 6 · see citing works
Self-citationNazif, N. N., Khosravi, M., Ahmadi, R., Bananej, M., & Majd, A. (2020) · PubMed Central · doi:10.22038/ijbms.2020.37707.8960 · Cited by 6 · see citing works
Jhan, K.-Y., Chen, K.-Y., Chang, P.-K., Chiu, C., Chou, C.-J., & Wang, L.-C. (2025) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2025.04.001 · Cited by 5 · see citing works
MAOA Influences the Trajectory of Attentional Development
Lundwall, R. A., & Rasmussen, C. G. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00424 · Cited by 5 · see citing works
Kim, M. J., Zhang, T., Kim, K. N., Bae, G. W., Yoon, S. M., Yu, Y., Wu, X., & Park, S. (2022) · Biology · doi:10.3390/biology11121739 · Cited by 5 · see citing works
Segat, H. J., Martini, F., Roversi, K., Rosa, S. G., Müller, S. G., Rossato, D. R., Nogueira, C. W., & Bürger, M. E. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113804 · Cited by 4 · see citing works
Brain neurotrophic supply in ontogenesis and during development of neurodegenerative diseases
Rudnitskaya, E. A., Kolosova, N. G., & Stefanova, N. A. (2016) · Moscow University Biological Sciences Bulletin · doi:10.3103/s009639251604009x · Cited by 4 · see citing works
de Oca, A. B.-M., Tendilla‐Beltrán, H., Bringas, M. E., Flores, G., & Aceves, J. (2024) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2024.102468 · Cited by 3 · see citing works
Adult Endogenous Dopaminergic Neuroregeneration Against Parkinson’s Disease: Ideal Animal Models?
Vijayanathan, Y., Lim, S. M., Tan, M. P., Lim, F. T., Majeed, A. B. A., & Ramasamy, K. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00298-7 · Cited by 4 · see citing works
Jeong, J., Won, S.-Y., Chung, Y. C., Shin, W.-H., Jin, B. K., & Park, E. S. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1746731 · Cited by 2 · see citing works
Integrating Dopamine and BDNF Hypotheses: The Role of Dopamine–BDNF Crosstalk in Neuropathologies
Alsalloum, M., Tsybko, A., & Naumenko, V. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297925604125 · Cited by 1 · see citing works
Brain-Derived Neurotrophic Factor and Its Clinical Applications
Mungmunpuntipantip, R., & Wiwanitkit, V. (2022) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_195_21 · Cited by 2 · see citing works
Sabaghi, A., Heirani, A., Kiani, A., & Yosofvand, N. (2018) · Neurophysiology · doi:10.1007/s11062-019-09759-y · Cited by 2 · see citing works
Pich, E. M., Cavalleri, L., Toma, C., & Collo, G. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_348 · Cited by 1 · see citing works
Li, J.-M., Yang, F.-H., Chao, M., & Tseng, C. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103755 · Cited by 2 · see citing works
Donahue, G. J., Lundari, J. A., Kane, P. W., Matamorose-Patrick, S. M., Klotz, J. E., Carr, N. L., Kudriavetz, S. C., & Brague, J. C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1828487 · Cited by 1 · see citing works
Goulding, S. R. (2021) · doi:10.34719/fhhg1227 · Cited by 1 · see citing works
Laboratorio de neuromorfologia, F. I., Gutiearrez, M. T., Martinez, V., Laboratorio de neuromorfologia, F. I., Gutiérrez-Valdez, A. L., Laboratorio de neuromorfologia, F. I., Ordóñez-Librado, J. L., Laboratorio de neuromorfologia, F. I., Fong, D. M., Departamento de fisiología, B. Y. N., et al. (2018) · International Journal of Advanced Research · doi:10.21474/ijar01/6501
Sabaghi, A., Heyrani, A., Kiani, A., Khazaee, H., Sabaghi, S., & Beygie, S. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.7.4.8
Obulesu, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819882-7.00001-5
Obulesu, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819882-7.00002-7
Rezaee, Z., Marandi, S. M., Alaei, H., & Esfarjani, F. (2020) · Medical Journal of Tabriz University of Medical Sciences and Health Services · doi:10.34172/mj.2020.045
Dysbiosis Of The Gut Microbiome Associated With Parkinson’s Disease Pathophysiology
Mierau, P. C. (2019) · UA Campus Repository (The University of Arizona)
Behavioral and Cytological Differences between Two Parkinson’s Disease Experimental Models
Ávila-Costa, M. R., Ordóñez-Librado, J. L., Gutiérrez-Valdez, A. L., Sánchez-Betancourt, J., Ibarra-Gutiérrez, M. T., Reyna-Velazquez, P. E., Anaya-Martı́nez, V., Caballero, C. A. G., Montiel-Flores, E., Dorado-Martı́nez, C., et al. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108268
Self-citationParkinson’s Disease - Animal Models, Current Therapies and Clinical Trials
Yenisetti, S. C., Koza, Z., Kumar, D., Singh, S. K., & Ganeshpurkar, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100831
Ramos, J. S., Chakraborty, R., Dalleck, L. C., Sarunic, K., Khadka, J., Haslam, T., & Nassaris, O. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1006221
Sabaghi, A., & Yousofvand, N. (2024) · Research Square · doi:10.21203/rs.3.rs-4208840/v1
Mascotte-Cruz, J. U., Vera, A., Leija, L., López-Salas, F. E., Gradzielski, M., Koetz, J., Gatica-García, B., Rodríguez-Oviedo, C. P., Valenzuela-Arzeta, I. E., Escobedo, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26701327
Self-citationKim, J. I., Yeo, H., Jo, Y., Kim, H., Park, S., & Kim, N. S. (2026) · Pain Research and Management · doi:10.1155/prm/3334432
- Authors
- Razgado-Hernandez, L. F., Espadas-Alvarez, A. J., Reyna-Velazquez, P., Sierra-Sanchez, A., Anaya-Martinez, V., Jimenez-Estrada, I., Bannon, M. J., Martinez-Fong, D., & Aceves-Ruiz, J.
- Affiliations
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (MX)
- Wayne State University (US)
- Corresponding author
- Aceves-Ruiz, Jorge
- ORCID
- Bannon, Michael J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-18
- Volume
- 10
- Issue
- 2
- Pages
- e0117391
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4332861
- OpenAlex
- W2052299360
- Cited by
- 90
- References
- 83
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 7 · 2023: 5 · 2022: 14 · 2021: 8 · 2020: 15 · 2019: 5 · 2018: 8 · 2017: 13 · 2016: 8 · 2015: 2
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Consejo Nacional de Ciencia y Tecnología (224222, 166638)
- Consejo Nacional de Ciencia y Tecnología, Paraguay
- National Institute on Drug Abuse (R01DA006470)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- Parkinson's disease, brain-derived neurotrophic factor, dopamine D3 receptor agonist, transfection, neurotensin receptor, substantia nigra, dendritic spines, motor behavior, 6-hydroxydopamine, aged rats, neuroprotection, non-viral gene delivery
- MeSH terms
- Animals, Biomechanical Phenomena, Disease Models, Animal, Gait, Male, Motor Activity, Muscles, Parkinson Disease, Psychomotor Performance, Regeneration, Transfection, Tyrosine 3-Monooxygenase, Neostriatum, Rats, Wistar, Dopamine Agonists, Brain-Derived Neurotrophic Factor, Recovery of Function, Dendritic Spines, Receptors, Dopamine D3, Rats, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review